[1] |
Warnakulasuriya S.Global epidemiology of oral and oropharyngeal cancer[J].Oral Oncol, 2009, 45(4/5):309-316
|
[2] |
Hsu HW, Wall NR, Hsueh CT, et al.Combination antiangiogenic therapy and radiation in head and neck cancers[J].Oral Oncol, 2014, 50(1):19-26
|
[3] |
Naruse T, Yanamoto S, Matsushita Y, et al.Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer: An investigation of distant metastasis[J].Mol Clin Oncol, 2016, 5(2):246-252
|
[4] |
Economopoulou P, Agelaki S, Perisanidis C, et al.The promise of immunotherapy in head and neck squamous cell carcinoma[J].Ann Oncol, 2016, 27(9):1675-1685
|
[5] |
Ebner OA, Selbach M.Quantitative proteomic analysis of gene regulation by miR34a and miR-34c[J].PLoS One, 2014, 9(3):e92166-
|
[6] |
Tarasov V, Jung P, Verdoodt B, et al.Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest[J].Cell Cycle, 2007, 6(13):1586-1593
|
[7] |
葛昕, 詹甜甜, 高洁,等.miR-34a通过下调SATB2抑制口腔鳞癌增殖、迁移和侵袭的初步研究[J].口腔生物医学, 2018, 9(1):1-6,16
|
[8] |
Kowal J, Tkach M, Théry C.Biogenesis and secretion of exosomes[J].Curr Opin Cell Biol, 2014, 29:116-125
|
[9] |
Wahlgren J, De L Karlson T, Brisslert M, et al.Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes[J].Nucleic Acids Res, 2012, 40(17):e130-
|
[10] |
Mathivanan S, Ji H, Simpson RJ.Exosomes: extracellular organelles important in intercellular communication[J].J Proteomics, 2010, 73(10):1907-1920
|
[11] |
Kharaziha P, Ceder S, Li Q, et al.Tumor cell-derived exosomes: a message in a bottle[J].Biochim Biophys Acta, 2012, 1826(1):103-111
|
[12] |
Didiot MC, Hall LM, Coles AH, et al.Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA Silencing[J].Mol Ther, 2016, 24(10):1836-1847
|
[13] |
Théry C, Amigorena S, Raposo G, et al.Isolation and characterization of exosomes from cell culture supernatants and biological fluids[J].Curr Protoc Cell Biol, 2006, 30(1):3.22.1-3.22.29
|
[14] |
Johnsen KB, Gudbergsson JM, Skov MN, et al.A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy[J].Biochim Biophys Acta, 2014, 1846(1):75-87
|
[15] |
Vader P, Mol EA, Pasterkamp G, et al.Extracellular vesicles for drug delivery[J].Adv Drug Deliv Rev, 2016, 106(Pt A):148-156
|
[16] |
Kim MS, Haney MJ, Zhao Y, et al.Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells[J].Nanomedicine, 2016, 12(3):655-664
|
[17] |
Kooijmans SAA, Stremersch S, Braeckmans K, et al.Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles[J].J Control Release, 2013, 172(1):229-238
|
[18] |
Haney MJ, Klyachko NL, Zhao Y, et al.Exosomes as drug delivery vehicles for Parkinson's disease therapy[J].J Control Release, 2015, 207:18-30
|
[19] |
O'Loughlin AJ, M?ger I, de Jong OG, et al.Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles[J].Mol Ther, 2017, 25(7):1580-1587
|
[20] |
Li YY, Tao YW, Gao S, et al.Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p[J].EBioMedicine, 2018, 36:209-220
|